Abstract
Transcranial magnetic stimulation (TMS) is a neuromodulation technique that was first approved for the treatment of major depressive disorder in 2008. Because of the success of TMS in treating depression, there has been interest in applications for other neuropsychiatric diseases. During the last several years, research has grown on the use of TMS for obsessive-compulsive disorder, schizophrenia, substance use disorders, anxiety disorders, posttraumatic stress disorder, Parkinson's disease, and chronic pain. This article provides a brief background of the current use of TMS in clinical practice and reviews the current data on the use of TMS in the treatment of depression and other neuropsychiatric disorders. [ Psychiatr Ann . 2016;46(11):637–641.]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
